Literature DB >> 34273145

Insulin: A 100-Year-Old Discovery With a Fascinating History.

William Rostène1, Pierre De Meyts2,3.   

Abstract

Diabetes has been known since antiquity. We present here a historical perspective on the concepts and ideas regarding the physiopathology of the disease, on the progressive focus on the pancreas, in particular on the islets discovered by Langerhans in 1869, leading to the iconic experiment of Minkowski and von Mering in 1889 showing that pancreatectomy in a dog induced polyuria and diabetes mellitus. Subsequently, multiple investigators searched for the active substance of the pancreas and some managed to produce extracts that lowered blood glucose and decreased polyuria in pancreatectomized dogs but were too toxic to be administered to patients. The breakthrough came 100 years ago, when the team of Frederick Banting, Charles Best, and James Collip working in the Department of Physiology headed by John Macleod at the University of Toronto managed to obtain pancreatic extracts that could be used to treat patients and rescue them from the edge of death by starvation, the only treatment then available. This achievement was quickly recognized by the Nobel Prize in Physiology or Medicine to Banting and Macleod in 1923. At 32, Banting remains the youngest awardee of this prize. Here we discuss the work that led to the discovery and its main breakthroughs, the human characters involved in an increasingly dysfunctional relationship, the controversies that followed the Nobel Prize, and the debate as to who actually "discovered" insulin. We also discuss the early commercial development and progress in insulin crystallization in the decade or so following the Nobel Prize.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Diabetes; Nobel Prize; discovery of insulin; insulin; pancreas; patents and therapeutic developments

Mesh:

Substances:

Year:  2021        PMID: 34273145     DOI: 10.1210/endrev/bnab020

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  2 in total

1.  Controversies in Selecting Nobel Laureates: An Historical Commentary.

Authors:  Marshall A Lichtman
Journal:  Rambam Maimonides Med J       Date:  2022-07-31

Review 2.  Structural principles of insulin formulation and analog design: A century of innovation.

Authors:  Mark A Jarosinski; Balamurugan Dhayalan; Yen-Shan Chen; Deepak Chatterjee; Nicolás Varas; Michael A Weiss
Journal:  Mol Metab       Date:  2021-08-21       Impact factor: 7.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.